Genmab AS - Company Profile
Powered by 
All the data and insights you need on Genmab AS in one report.
$295
- Save hours of research time and resources with
our up-to-date Genmab AS Strategy Report
- Understand Genmab AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Genmab AS’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Genmab AS's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Deirdre P. Connelly
Chairman Executive BoardMs. Deirdre P. Connelly has been the Chairman of the company since 2017. Prior to this, she served as the President of North America Pharmaceuticals for GlaxoSmithKline Plc from 2009 to 2015. Ms. Connelly also serves as the Director of Lincoln Financial Corporation and Macy’s Inc.
Jan G. J. Van de Winkel, Ph.D.
Chief Executive Officer; President Senior ManagementDr. Jan G.J. Van de Winkel has been the President and Chief Executive Officer of the company since 2010. Prior to this, he served as the Scientific Director and the Vice President of Medarex Europe. Mr. Winkel holds a professorship in Immunotherapy at Utrecht University.
Anthony Pagano
Executive Vice President; Chief Financial Officer Senior ManagementMr. Anthony Pagano has been the Executive Vice President and Chief Financial Officer of the company since March 2020. Prior to this, he served as the Corporate Controller and Senior Director of Business Planning at NovaDel Pharma.
Anthony Mancini
Executive Vice President; Chief Operating Officer Senior ManagementMr. Anthony Mancini has been the Executive Vice President and Chief Operating Officer of the company since March 2020. Prior to this, he served as the Senior Vice President at Bristol-Myers Squibb.
Martine van Vugt
Chief Strategy Officer; Executive Vice President Senior ManagementMs. Martine van Vugt has been the Executive Vice President and Chief Strategy Officer of the company since March 2023. Prior to this, she served as a Senior Vice President, Corporate Strategy & Planning.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer